期刊文献+

河北省脊髓灰质炎实验室监测结果分析

ANALYSIS ON SURVEILLANCE OF POLIO LABORATORY IN HEBEI PROVINCE 2003-2004
下载PDF
导出
摘要 目的:分析河北省脊髓灰质炎(脊灰)实验室的监测状况,及时监测可能出现的脊髓灰质炎疫苗衍生株(VDPV)或输入脊灰野病毒,以防止其扩散。方法:按世界卫生组织《脊髓灰质炎病毒检验手册》进行病毒分离与血清定型,用PCR—RFLP法和ELISA法做型内鉴定。结果:河北省脊灰实验室各项监测指标均达到世界卫生组织和卫生部的要求。2003-2004年共采集了743例急性驰缓性麻痹(AFP)病例粪例标本,所有标本用L20B、RD和Hep-23种细胞同时进行肠道病毒分离。分离到脊灰病毒(PV)67株,非脊灰肠道病毒(NPEV)74株。从AFP病例及其密切接触者粪便标本中共分离到P、79株,用血清型中和试验和PCR—RFLP法进行型内鉴定,结果为Ⅰ型8株,Ⅱ型24株,Ⅲ型20株,混合型15株,PV+NPEV7株,疫苗变异株5株。将PV混合株进行单型分离后,所有单型毒株共107株,经ELISA试验鉴定,其中疫苗类似株(SL)104株,占97.2%,双反应株(DRV)17株,占2.8%。结论:河北省2003-2004年未发现疫苗衍生脊灰病毒或输人性脊灰野病毒。 Objective: To study the surveillance indicators in polio laboratory of Hebei, to Survell VDPV or wild - type poliovirus in time. Methods: According to WHO's normal method to isolated virus and neutralization test, intratypic differentiation test was carried out to all AFP isolated using PCR- RFLP and ELISA methods. Results: All the surveillance indicators in polio laboratory of hebei met the requirements of WHO and MOH. There were 743 stools which collected in 2003 - 2004. All stool .samples were also made viral isolation by, L20B cell, RD cell and Hep - 2 cell. 67 polioviruses were isolation from AFP cases. 74 of nonpolio enteroviruses (NPEV) were also isolated from AFP cases. Among 79 isolates, 8 of type I vaccine- like viyuses, 24 of type 2 vaccine- like Cruses, 20 of type 3 vaccine- like viruses, 15 of mixed viruses, 7 of vaccine- like viruses mixed with enteroviruses, 5 viruses were identified as mutant viruses. Then ELISA test was conducted, cording to WHO manual, among total 107 single serotype viruses, 104 of sabin-like viruses (SL), 3 of double reaction viruses (DRV). Conclusion: No wild polioviruses or VDPVs were found in Hebei. maintaining a nopolio wild- type virus status in Hebei.
出处 《现代预防医学》 CAS 北大核心 2005年第12期1668-1669,共2页 Modern Preventive Medicine
关键词 脊髓灰质炎病毒 急性驰缓性麻痹 脊髓灰质炎疫苗衍生株 Poliovirus: Acute Flaccid Paralysis (AFP) Vaccine-derived poliovirus (VDPV)
  • 相关文献

参考文献6

  • 1张勇,祝双利,赵蓉,李杰,陈立,侯晓辉,王东艳,张礼璧,许文波.中国急性弛缓性麻痹(AFP)病例中脊髓灰质炎病毒疫苗株VP1区基因变异的研究[J].病毒学报,2004,20(1):28-33. 被引量:50
  • 2Hull HF,Aylward RB.Invited commentary:The scientific basis for stopping polio immunization[J].Am J Epidemiol,1999,150(10):1022-1025.
  • 3Yang C F,Naguib T,Yang SJ,et al.Circulation of endemic type 2 vaccine-derived poliovirus in Egypt,1983 to 1993[J].Journal of virology,2003,77:8366-8377.
  • 4Kew O,Glasgow V M,Landaverde M,et al.Outbreak of Polionyelitis in Hispaniola Associated with Circulating Type Ⅰ Vaccine-derived poliovirus[J].Science,2002,296:356-359.
  • 5Thorley B,paladin F,Shimizu H.Poliomyelitis due to vaccine-derived polioviruses in the Philippines.In:Abstracts of the Ⅱth International congress of virplogy,Paris,27 July to 1 August 2002.Paris:International Union of Microbiological Societies;2002.
  • 6Rousset D,Rakoto-Andrianarivelo M,Razafindratsimandresy R,etc.Recombinant vaccine-derived poliovirus in Madagascar[J].Emerging Infectious Diseases,2003;885-887.

二级参考文献14

  • 1[1]Horaud F,Albert B.Sabin and the development of oral polio vaccine[J].Biological,1993,21:311-316.
  • 2[2]Kew O M,Nottay B K,Hatch M H,et al.Multiple genetic changes can occur in the oral polio vaccines upon replication in humans[J].J Gen Virol,1998,156:337-347.
  • 3[3]Balanat J,Guillot S,Candrea A,et al.The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay[J].Virology,1991,184:645-654.
  • 4[4]Bouchard M J,Lam D H,Racaniello V R,et al.Determinants of Attenuation and Temperature Sensitivity in the Type Ⅰ Poliovirus Sabin Vaccine[J].J Virology,1995,69(8):4972-4978.
  • 5[5]Ren R B,Moss E G,Racaniello V R,et al.Identification of Two Determinants that Attenuate Vaccine-Related Type Ⅱ Poliovirus[J].J Virology,1991,65(3):1377-1382.
  • 6[6]Almond J W,Westrop G D,Evans D M A,et al.Studies on the Attenuation of the Sabin Type Ⅲ Oral Polio Vaccine[J].J Virol Meth,1987,17:183-189.
  • 7[7]Joce R,Wood D,Brown D,et al.Paralytic Poliomyelitis in England and Wales,1985-91[J].Br Med J,1992,305:79-82.
  • 8[8]Almond J W.The Attenuation of Poliovirus Neurovirulence[J].Microbiol,1987,41:153-180.
  • 9[9]Minor P D,Macadam A J,Stone D M,et al.Genetic Basis of Attenuation of the Sabin Oral Poliovirus Vaccines[J].Biological,1993,21:357-363.
  • 10[10]Friedrich F.Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans[J].Acta Virologica,1998,42:187-195.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部